We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Association of Interleukin 23 Receptor Polymorphisms with Predisposition to Rheumatoid Arthritis: An Updated Meta and Trial Sequential Analysis

    The etiology of Rheumatoid Arthritis (RA) development remained unclear, and several factors, such as environmental, genetic, and immune system...

    Surjyapratap Sarangi, Debashis Barik, ... Aditya K. Panda in Biochemical Genetics
    Article 25 January 2024
  2. Interleukin-23

    Christine Huppertz, Amanda Littlewood-Evans in Encyclopedia of Molecular Pharmacology
    Reference work entry 2021
  3. Interleukin-23

    Christine Huppertz, Amanda Littlewood-Evans in Encyclopedia of Molecular Pharmacology
    Living reference work entry 2021
  4. Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis

    Acetylcholine receptor (AChR) myasthenia gravis (MG) is a chronic autoimmune disease characterized by muscle weakness. The AChR + autoantibodies are...

    José A. Villegas, Jérôme Van Wassenhove, ... Nadine Dragin in Journal of Neuroinflammation
    Article Open access 13 January 2023
  5. Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A

    Abstract

    Interleukin (IL)-17A-producing T helper (Th)17 cells are increasingly being acknowledged to be associated with protective immunity to Mycobact...

    Kristina Ritter, Jochen Behrends, ... Christoph Hölscher in Journal of Molecular Medicine
    Article Open access 05 August 2021
  6. Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model

    Background

    Interleukin 23 is a critical cytokine in the pathogenesis of multiple sclerosis. But the local impact of interleukin 23 on the course of...

    Louisa Nitsch, Simon Petzinna, ... Marcus Müller in Journal of Neuroinflammation
    Article Open access 27 April 2021
  7. Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis

    Rheumatic diseases are complex autoimmune diseases which include among others rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), and...

    Izabela Woś, Jacek Tabarkiewicz in Immunologic Research
    Article Open access 29 January 2021
  8. Rs-10889677 variant in interleukin-23 receptor may contribute to creating an inflammatory milieu more susceptible to bladder tumourigenesis: report and meta-analysis

    Bladder cancer (BLC) is a recurrent high-risk malignancy typified by an inherent localised chronic inflammation. IL-23-receptor (IL-23R), as a...

    Mohammed El-Gedamy, Zakaria El-khayat, ... Eslam El-Nahrery in Immunogenetics
    Article 04 March 2021
  9. Interleukin 23 and autoimmune diseases: current and possible future therapies

    Purpose

    IL-23 is a central proinflammatory cytokine with a wide range of influence over immune response. It is implicated in several autoimmune...

    Ahmad Ismail Khaled Abdo, Gee Jun Tye in Inflammation Research
    Article 25 March 2020
  10. Interleukin-1β and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine

    Introduction : Common Variable Immunodeficiency (CVID) is the most common symptomatic form of primary immunodeficiencies. Current research data show...

    Laleh Sharifi, Asghar Aghamohammadi, ... Abbas Mirshafiey in European Cytokine Network
    Article 01 December 2019
  11. Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma

    Nonallergic eosinophilic asthma (NAEA) is a clinically distinct subtype of asthma. Thus far, the pathophysiologic mechanisms underlying NAEA have not...

    Hyun Seung Lee, Da-Eun Park, ... Heung-Woo Park in Experimental & Molecular Medicine
    Article Open access 20 January 2020
  12. Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

    Psoriasis is a systemic immune-mediated disease associated with an increased risk of comorbidities, such as psoriatic arthritis, cardiovascular...

    Yuxiong Jiang, Youdong Chen, ... Yuling Shi in BioDrugs
    Article Open access 02 January 2023
  13. Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression

    Psoriasis is a chronic inflammatory skin disorder characterized by abnormal keratinocytes proliferation and multiple immune cells infiltration in the...

    Lipeng Tang, Bowen Zhang, ... Guangjuan Zheng in Journal of Natural Medicines
    Article 12 June 2023
  14. Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis based on randomized controlled trials

    In recent years, the use of interleukin (IL) 23 inhibitors in the treatment of psoriatic arthritis (PsA) has been the subject of much research. By...

    **ao**g Huang, Haojie Shentu, ... Haowei Zhu in Immunologic Research
    Article Open access 22 February 2023
  15. Probiotics ameliorate endocrine disorders via modulating inflammatory pathways: a systematic review

    Probiotics has offered a new prospect to treat and manage a variety of endocrine disorders such as obesity, diabetes, non- alcoholic fatty liver...

    Marzieh Nemati, Bahareh Ebrahimi, Nima Montazeri-Najafabady in Genes & Nutrition
    Article Open access 19 March 2024
  16. Association of IL-23R and IL-10 variations with Behçet disease: a genetic analysis study

    Behçet disease (BD) is an autoimmune and autoinflammatory disease mainly affecting the Silk Road countries. The interindividual severity of BD...

    Guven Yenmis, Sema Sabancelebi, ... Tumay Sadikoglu in Immunologic Research
    Article 13 November 2023
  17. Critical role of interleukin-23 in development of asthma promoted by cigarette smoke

    Abstract

    It has been recently reported that cigarette smoke exposure during allergen sensitization facilitates the development of allergic asthma;...

    Hyun Seung Lee, Da-Eun Park, ... Sang-Heon Cho in Journal of Molecular Medicine
    Article 24 April 2019
  18. IL-23 stabilizes an effector Treg cell program in the tumor microenvironment

    Interleukin-23 (IL-23) is a proinflammatory cytokine mainly produced by myeloid cells that promotes tumor growth in various preclinical cancer models...

    Tobias Wertheimer, Pascale Zwicky, ... Burkhard Becher in Nature Immunology
    Article Open access 14 February 2024
  19. Tumor Microenvironment The Role of Interleukins – Part B

    Revealing essential roles of the tumor microenvironment in cancer progression, this book provides a comprehensive overview of the latest research on...

    Book 2021
Did you find what you were looking for? Share feedback.